An Act to Amend the Maine Medical Use of Cannabis Act
Maine Legislature, Session 132, LD 1840
Committee: Veterans and Legal Affairs
Sponsors: HICKMAN, BOYER
Amends: 22 MRSA §2421-A, 22 MRSA §2422-A, 22 MRSA §2423-A, 22 MRSA §2423-F, 22 MRSA §2425-A, 22 MRSA §2428, 22 MRSA §2429-D, 22 MRSA §2430-N

Legislative Document
No. 1840
S.P. 723
In Senate, April 30, 2025
An Act to Amend the Maine Medical Use of Cannabis Act
Reference to the Committee on Veterans and Legal Affairs suggested and ordered printed.
DAREK M. GRANT
Secretary of the Senate
Presented by Senator HICKMAN of Kennebec.
Cosponsored by Representative BOYER of Poland and
Senators: BENNETT of Oxford, FARRIN of Somerset, TALBOT ROSS of Cumberland, 
TIMBERLAKE of Androscoggin, TIPPING of Penobscot, Representatives: FREDERICKS of 
Sanford, OSHER of Orono, SUPICA of Bangor.
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  22 MRSA §2421-A, sub-§12, as enacted by PL 2023, c. 679, Pt. A, §3, is 
amended to read:
12.  Caregiver retail store.  "Caregiver retail store" means a retail store authorized in 
accordance with this chapter and used by that has regular business hours at a location 
accessible to the general public where a registered caregiver to sell sells cannabis 
paraphernalia, cannabis plants, harvested cannabis, related supplies or educational 
materials to qualifying patients without an appointment and other items to the general 
public at a fixed location.  "Caregiver retail store" does not include an office at a location 
not accessible to the general public where a registered caregiver provides consultation 
services, cannabis paraphernalia, cannabis plants, harvested cannabis, related supplies or 
educational materials to qualifying patients by appointment.
Sec. 2.  22 MRSA §2421-A, sub-§27, as enacted by PL 2023, c. 679, Pt. A, §3, is 
amended to read:
27.  Manufacturing facility.  "Manufacturing facility" means a registered tier 1 or tier 
manufacturing facility or a person authorized to engage in cannabis extraction in 
accordance with this chapter.
Sec. 3.  22 MRSA §2421-A, sub-§42, as enacted by PL 2023, c. 679, Pt. A, §3, is 
amended to read:
42.  Registrant.  "Registrant" means a registered caregiver, dispensary, cannabis 
testing facility, or manufacturing facility or person authorized to engage in cannabis 
extraction using inherently hazardous substances under this chapter.  
Sec. 4.  22 MRSA §2421-A, sub-§43, as enacted by PL 2023, c. 679, Pt. A, §3, is 
amended to read:
43.  Registrant agent.  "Registrant agent" means an assistant, employee, officer, 
director or other authorized agent of a registered caregiver, dispensary, cannabis testing 
facility, or manufacturing facility or person authorized to engage in cannabis extraction 
using inherently hazardous substances under this chapter.   
Sec. 5.  22 MRSA §2422-A, as repealed and replaced by PL 2023, c. 365, §1, is 
amended by amending the section headnote to read:
§2422-A.  Administration and enforcement; rulemaking; forms and guidance 
documents
Sec. 6.  22 MRSA §2422-A, sub-§3 is enacted to read:
3.  Forms and guidance documents.  Except where explicitly authorized or directed 
under this chapter, the department may not:
A.  Require a registered caregiver, dispensary, cannabis testing facility or 
manufacturing facility to use a form issued by the department in complying with the 
requirements of this chapter or the rules adopted pursuant to this chapter; or
B.  Issue a guidance document or memorandum to registered caregivers, dispensaries, 
cannabis testing facilities or manufacturing facilities regarding compliance with the 
requirements of this chapter or the rules adopted pursuant to this chapter.
Sec. 7.  22 MRSA §2423-A, sub-§1, ¶J, as repealed and replaced by PL 2019, c. 
331, §7 and amended by PL 2021, c. 669, §5, is further amended to read:
J.  Manufacture cannabis products and cannabis concentrate for medical use, including 
through the use of inherently hazardous substances in accordance with section 2423-F, 
subsection 3-A and the applicable rules adopted pursuant to section 2423-F, subsection 
10, except that a qualifying patient may not manufacture food, as defined in section 
2152, subsection 4, unless the qualifying patient is licensed pursuant to section 2167 
and except that a qualifying patient may not produce cannabis concentrate using 
inherently hazardous substances unless authorized pursuant to section 2423‑F, 
subsection 3;
Sec. 8.  22 MRSA §2423-A, sub-§2, ¶E, as amended by PL 2017, c. 452, §4 and 
amended by PL 2021, c. 669, §5, is repealed.
Sec. 9.  22 MRSA §2423-A, sub-§2, ¶G, as repealed and replaced by PL 2019, c. 
331, §9 and amended by PL 2021, c. 669, §5, is further amended to read:
G.  Manufacture cannabis products and cannabis concentrate for medical use, including 
through the use of inherently hazardous substances in accordance with section 2423-F, 
subsection 3-A and the applicable rules adopted pursuant to section 2423-F, subsection 
10, except that a caregiver may not manufacture food, as defined in section 2152, 
subsection 4, unless the caregiver is licensed pursuant to section 2167 and except that 
a caregiver may not produce cannabis concentrate using inherently hazardous 
substances unless authorized pursuant to section 2423‑F, subsection 3;
Sec. 10.  22 MRSA §2423-A, sub-§2, ¶O, as enacted by PL 2017, c. 452, §4 and 
amended by PL 2021, c. 669, §5, is further amended to read:
O.  Transport, sell, offer to sell or furnish  cannabis plants or harvested cannabis for 
authorized conduct in accordance with this chapter on the property or premises owned, 
leased or rented by the caregiver; at trade shows, festivals or other cannabis industry-
related events; or through delivery to or private arrangement with a qualifying patient, 
caregiver or registered dispensary;
Sec. 11.  22 MRSA §2423-F, as amended by PL 2023, c. 679, Pt. A, §8, is further 
amended by amending the section headnote to read:
§2423-F.  Cannabis manufacturing facilities; cannabis extraction
Sec. 12.  22 MRSA §2423-F, first ¶, as repealed and replaced by PL 2019, c. 331, 
§17 and amended by PL 2021, c. 669, §5, is repealed and the following enacted in its place:
This section governs the manufacture of cannabis products and cannabis concentrate 
and cannabis extraction by cannabis manufacturing facilities and other persons.
Sec. 13.  22 MRSA §2423-F, sub-§3, as repealed and replaced by PL 2019, c. 331, 
§17 and amended by PL 2021, c. 669, §5, is repealed.
Sec. 14.  22 MRSA §2423-F, sub-§3-A is enacted to read:
3-A.  Extraction using inherently hazardous substances.  A qualifying patient, 
registered caregiver, registered dispensary or manufacturing facility may engage in 
cannabis extraction using inherently hazardous substances if the qualifying patient, 
registered caregiver, registered dispensary or manufacturing facility complies with the rules 
adopted by the department pursuant to subsection 10 governing cannabis extraction using 
inherently hazardous substances.  A person that is not a qualifying patient, registered 
caregiver, registered dispensary or manufacturing facility may not engage in cannabis 
extraction using inherently hazardous substances.
Sec. 15.  22 MRSA §2423-F, sub-§4, ¶A, as repealed and replaced by PL 2019, c. 
331, §17 and amended by PL 2021, c. 669, §5, is further amended to read:
A.  May manufacture cannabis products and cannabis concentrate for medical use using 
any method that does not, including methods that involve use of an inherently 
hazardous substance, except that a registered manufacturing facility may manufacture 
cannabis concentrate using inherently hazardous substances if authorized under 
subsection 3 in accordance with subsection 3-A and the applicable rules adopted 
pursuant to subsection 10;
Sec. 16.  22 MRSA §2423-F, sub-§5, as amended by PL 2021, c. 367, §9 and c. 
669, §5, is repealed.
Sec. 17.  22 MRSA §2423-F, sub-§6, as repealed and replaced by PL 2019, c. 331, 
§17 and amended by PL 2021, c. 669, §5, is further amended to read:
6.  Retail sale prohibited.  A registered manufacturing facility or a person authorized 
to engage in cannabis extraction using inherently hazardous substances under subsection 3 
may not engage in retail sales of cannabis products or cannabis concentrate unless the 
person is authorized to engage in retail sales under this chapter.
Sec. 18.  22 MRSA §2423-F, sub-§7, as repealed and replaced by PL 2019, c. 331, 
§17 and amended by PL 2021, c. 669, §5, is further amended to read:
7.  Food establishment license required to manufacture food products.  A 
registered manufacturing facility or a person authorized to produce cannabis concentrate 
using inherently hazardous substances may not manufacture edible cannabis products or 
cannabis tinctures unless licensed pursuant to section 2167.
Sec. 19.  22 MRSA §2423-F, sub-§8, as repealed and replaced by PL 2019, c. 331, 
§17 and amended by PL 2021, c. 669, §5, is further amended to read:
8.  Registration requirements.  This subsection governs the registration requirements 
of a manufacturing facility or a person authorized to engage in cannabis extraction using 
inherently hazardous substances under subsection 3 and of the officer or director or 
assistant of the facility or person.
A.  In accordance with rules adopted under subsection 10, the department shall register 
and issue a registration certificate with a registry identification number to a 
manufacturing facility or a person authorized to engage in cannabis extraction within 
days to the facility or person if the facility or person provides:
(1)  The applicable annual fee required pursuant to section 2425‑A, subsection 10;
(2)  The legal name of the facility or person and, if incorporated, evidence of 
incorporation and evidence that the corporation is in good standing with the 
Secretary of State;
(3)  The physical address of the facility or person or the physical address where an 
applicant who is an individual will engage in the activities authorized under this 
section. If the physical address of the facility or person changes its physical 
location, or if a person registered under this subsection changes the location at 
which the person engages in activities authorized under this section, the facility or 
person shall notify the department of the new location address; and
(4)  The name, address and date of birth of each officer or director of the facility 
or person.
B.  In accordance with rules adopted under subsection 10, the department shall issue 
registry identification cards to the officer or director or assistant of a registered 
manufacturing facility or person authorized to engage in cannabis extraction using 
inherently hazardous substances within 5 business days of approving an application or 
renewal under this subsection. A registry identification card is required to be issued to 
an officer or director or assistant of a registered manufacturing facility or person 
authorized to engage in cannabis extraction using inherently hazardous substances.  A 
registry identification card expires one year after the date of issuance. A registry 
identification card issued under this paragraph must contain:
(1)  The name of the cardholder;
(2)  The date of issuance and expiration date of the registry identification card; and
(3)  A random identification number that is unique to the cardholder.
The department may not issue a registry identification card to an officer or director or 
assistant of a registered manufacturing facility or person authorized to engage in 
cannabis extraction using inherently hazardous substances who has been convicted of 
a disqualifying drug offense. The department shall conduct a criminal history record 
check of each person, officer or director or assistant subject to this subsection on an 
annual basis.
If the department determines not to issue a registry identification card for a person, to 
an officer or director or assistant of a manufacturing facility, the department shall notify 
the registered manufacturing facility or person authorized to engage in cannabis 
extraction using inherently hazardous substances in writing of the reason for denying 
the registry identification card.
Sec. 20.  22 MRSA §2423-F, sub-§10, as amended by PL 2021, c. 367, §10; c. 387, 
§5; and c. 669, §5, is further amended to read:
10.  Rulemaking.  The department shall adopt routine technical rules as defined in 
Title 5, chapter 375, subchapter 2‑A, except that, beginning July 1, 2021, rules adopted 
pursuant to this subsection are major substantive rules as defined in Title 5, chapter 375, 
subchapter 2‑A, governing the registration and operation of manufacturing facilities, 
including and cannabis extraction using inherently hazardous substances.  The rules must 
include, but are not limited to:
A.  Requirements for the registration of a manufacturing facility and an officer or 
director or assistant of a registered manufacturing facility;
B.  Requirements for engaging in cannabis extraction using inherently hazardous 
substances by manufacturing facilities and by qualifying patients, registered caregivers 
and registered dispensaries;
C.  Manufacturing facility officer or director qualification requirements;
D.  Required security for manufacturing facilities;
E.  Requirements of a disposal plan for harvested cannabis used in the manufacturing 
process; and
F.  Minimum record-keeping requirements.
The failure of the department to adopt rules under this subsection does not prevent a person 
authorized pursuant to subsection 3, paragraph A 3-A from engaging in conduct authorized 
under this section.
Rules adopted or amended by the department pursuant to this subsection on or after July 1, 
2021 are major substantive rules as defined in Title 5, chapter 375, subchapter 2-A.
Sec. 21.  22 MRSA §2423-F, sub-§11, as repealed and replaced by PL 2019, c. 
331, §17 and amended by PL 2021, c. 669, §5, is repealed and the following enacted in its 
place:
11.  Multiple authorizations; cannabis possession allowances.  A manufacturing 
facility that is also a qualifying patient, registered caregiver or registered dispensary may 
possess the amount of cannabis allowed for that facility under this section in addition to the 
amount of cannabis allowed for a qualifying patient, registered caregiver or registered 
dispensary under this chapter, as long as the cannabis possessed as a manufacturing facility 
under this section is distinguishable from the cannabis possessed as a qualifying patient, 
registered caregiver or registered dispensary under this chapter.
Sec. 22.  22 MRSA §2423-F, sub-§12, as amended by PL 2023, c. 679, Pt. A, §8, 
is further amended to read:
12.  Record keeping.  A registered manufacturing facility or person authorized to 
engage in cannabis extraction using inherently hazardous substances under subsection 3 
shall maintain records of all transactions in accordance with section 2430‑J.
Sec. 23.  22 MRSA §2425-A, sub-§10, ¶F, as enacted by PL 2017, c. 452, §12 and 
amended by PL 2021, c. 669, §5, is repealed.
Sec. 24.  22 MRSA §2425-A, sub-§14, ¶D, as enacted by PL 2023, c. 637, §2, is 
amended by enacting at the end a new first blocked paragraph to read:
The department may not post on its publicly accessible website or otherwise make 
publicly available, except upon request, applications, supporting information and other 
nonconfidential information regarding a registered caregiver, including any address 
where the registered caregiver cultivates, manufactures, tests, packages, stores or sells 
cannabis plants or harvested cannabis under this chapter.
Sec. 25.  22 MRSA §2428, sub-§1-A, ¶I, as enacted by PL 2017, c. 452, §16 and 
amended by PL 2021, c. 669, §5, is further amended to read:
I.  Manufacture cannabis concentrate for medical use, except that a dispensary may not 
produce cannabis concentrate using including through the use of inherently hazardous 
substances unless authorized pursuant to section 2423‑F, subsection 3 in accordance 
with section 2423-F, subsection 3-A and the applicable rules adopted pursuant to 
section 2423-F, subsection 10;
Sec. 26.  22 MRSA §2429-D, as amended by PL 2019, c. 217, §5 and PL 2021, c. 
669, §5, is further amended to read:
§2429-D.  Local regulation
Pursuant to the home rule authority granted under the Constitution of Maine, Article 
VIII, Part Second and Title 30‑A, section 3001, a municipality may regulate registered 
caregivers, caregiver retail stores operating pursuant to section 2423‑A, subsection 2, 
paragraph P, registered dispensaries, cannabis testing facilities and manufacturing 
facilities.
A municipality may not:
1.  Registered caregivers.  Prohibit or limit the number of registered caregivers;
2.  Stores, dispensaries, testing and manufacturing facilities.  Prohibit caregiver 
retail stores, registered dispensaries, cannabis testing facilities and manufacturing facilities 
that are operating with municipal approval in the municipality prior to the effective date of 
this section.  For purposes of this subsection, "municipal approval" means an examination 
and approval of the store, dispensary or facility for the use of the premises consistent with 
conduct authorized under this chapter, including, but not limited to, a conditional use 
approval or site plan approval.  "Municipal approval" does not include issuance of a 
building, electrical or other similar permit or authorization that does not address the use of 
the structure or facility for which the permit or authorization is issued; or
3.  Municipal authorization needed.  Authorize caregiver retail stores, registered 
dispensaries, cannabis testing facilities and manufacturing facilities that are not operating 
on the effective date of this section to operate in the municipality unless the municipal 
legislative body, as defined in Title 30‑A, section 2001, subsection 9, has voted to adopt or 
amend an ordinance or approve a warrant article allowing caregiver retail stores, registered 
dispensaries, cannabis testing facilities or manufacturing facilities, as applicable, to operate 
within the municipality.
Notwithstanding any provision of this chapter or the rules adopted pursuant to this 
chapter to the contrary, the department may not require a caregiver retail store, registered 
dispensary, cannabis testing facility or manufacturing facility to use a form provided by the 
department to demonstrate municipal approval or other local authorization, if such approval 
or authorization is required by the municipality in which the caregiver retail store, 
registered dispensary, cannabis testing facility or manufacturing facility is seeking to 
operate.
Notwithstanding any provision of this chapter or the rules adopted pursuant to this 
chapter to the contrary, a caregiver retail store, registered dispensary, cannabis testing 
facility or manufacturing facility that, prior to January 1, 2026, was issued by the 
department a registration or other authorization to operate and was subsequently denied 
such registration or other authorization based solely on the failure of the caregiver retail 
store, registered dispensary, cannabis testing facility or manufacturing facility to obtain a 
completed form provided by the department to demonstrate municipal approval or other 
local authorization, or based solely on the failure of the municipality to adopt or amend an 
ordinance or approve a warrant article as required by subsection 3, is deemed in compliance 
with applicable municipal approval or local authorization requirements under this chapter.  
A caregiver retail store, registered dispensary, cannabis testing facility or manufacturing 
facility deemed in compliance with applicable municipal approval or local authorization 
requirements pursuant to this paragraph may request and the department shall issue a 
registration or other authorization to renew operations, as long as: the caregiver retail store, 
registered dispensary, cannabis testing facility or manufacturing facility is to be located in 
the same municipality in which it was located when last issued a registration or other 
authorization to operate by the department; and the caregiver retail store, registered 
dispensary, cannabis testing facility or manufacturing facility satisfies all other applicable 
registration or authorization requirements pursuant to this chapter and the rules adopted 
pursuant to this chapter, excluding any such requirements relating to municipal approval 
or local authorization and any such requirements that the caregiver retail store, registered 
dispensary, cannabis testing facility or manufacturing facility maintain continuous 
operation since it was last issued a registration or other authorization to operate by the 
department.
Sec. 27.  22 MRSA §2430-N, sub-§8, as enacted by PL 2023, c. 365, §25, is 
amended to read:
8.  Sales Gross sales; sales tax revenue.  The gross sales of cannabis for medical use 
for the current and prior fiscal years and the sales tax revenue from the sale of cannabis for 
medical use deposited into the General Fund for the current and prior fiscal years.
Sec. 28.  Department of Administrative and Financial Services, Office of 
Cannabis Policy; medical cannabis research grant program rulemaking.  On or 
before January 9, 2026, the Department of Administrative and Financial Services, Office 
of Cannabis Policy shall provisionally adopt and submit for legislative review rules 
necessary to implement the medical cannabis research grant program in accordance with 
the Maine Revised Statutes, Title 22, section 2430, subsection 5.  Rules adopted by the 
office pursuant to this section are major substantive rules as defined in Title 5, chapter 375, 
subchapter 2-A.
Sec. 29.  Department of Administrative and Financial Services, Office of 
Cannabis Policy; forms and guidance documents.  The Department of 
Administrative and Financial Services, Office of Cannabis Policy shall as expeditiously as 
possible review all public forms and guidance documents issued or made available by the 
office to determine whether such forms and documents comply with the requirements of 
the Maine Revised Statutes, Title 22, section 2422-A, subsection 3.  The office shall ensure 
that any such forms and documents determined to not comply with those requirements are 
rescinded, removed from the office's publicly accessible website and no longer made 
available through the office.  The forms to be rescinded, removed and no longer made 
available must include, but are not limited to, any form or other document designed to be 
used by a caregiver retail store, registered dispensary, cannabis testing facility or 
manufacturing facility to demonstrate municipal approval or other local authorization, 
consistent with the prohibition on such form under Title 22, section 2429-D.
Sec. 30.  Department of Administrative and Financial Services, Office of 
Cannabis Policy; registered caregiver information.  In accordance with the Maine 
Revised Statutes, Title 22, section 2425-A, subsection 14, paragraph D, the Department of 
Administrative and Financial Services, Office of Cannabis Policy shall as expeditiously as 
possible remove from the office's publicly accessible website all applications, supporting 
information and other nonconfidential information regarding a registered caregiver, 
including any address where the registered caregiver cultivates, manufactures, tests, 
packages, stores or sells cannabis plants or harvested cannabis pursuant to the Maine 
Medical Use of Cannabis Act, and shall otherwise ensure that such information is no longer 
made publicly available, except upon request.
SUMMARY
This bill makes the following changes to the Maine Medical Use of Cannabis Act.
1.  It amends the definition of "caregiver retail store" to clarify that it is a retail store 
with regular business hours at a location accessible to the general public where a registered 
caregiver sells cannabis paraphernalia, cannabis plants, harvested cannabis, related 
supplies or educational materials to qualifying patients without an appointment and other 
items to the general public.  It provides that a caregiver retail store does not include an 
office at a location not accessible to the general public where a registered caregiver 
provides consultation services, cannabis paraphernalia, cannabis plants, harvested 
cannabis, related supplies or educational materials to qualifying patients by appointment.
2.  It prohibits the Department of Administrative and Financial Services, except where 
explicitly authorized or directed by law, from requiring a registered caregiver, registered 
dispensary, cannabis testing facility or manufacturing facility to use a form issued by the 
department in complying with the requirements of the Act or of adopted rules and from 
issuing a guidance document or memorandum to such persons regarding compliance by 
those persons with the requirements of the Act or of adopted rules.  The bill directs the 
department’s Office of Cannabis Policy to, as expeditiously as possible, rescind and 
remove from public availability any noncompliant forms and guidance documents or 
memoranda.
3.  It repeals the provision of law that authorizes a caregiver to receive reasonable 
monetary compensation for costs associated with cultivating cannabis plants or assisting a 
qualifying patient with that patient's medical use of cannabis.
4.  It provides that a caregiver is authorized to transport, sell, offer to sell or furnish 
cannabis plants or harvested cannabis on the property or premises owned, leased or rented 
by the caregiver; at trade shows, festivals or other cannabis industry-related events; or 
through delivery to or private arrangement with a qualifying patient, caregiver or registered 
dispensary.
5.  It removes the process under the Act by which a person that is not a qualifying 
patient, registered caregiver, registered dispensary or manufacturing facility may receive 
authorization from the department to engage in cannabis extraction using an inherently 
hazardous substance and prohibits such cannabis extraction other than by qualifying 
patients, registered caregivers, registered dispensaries or manufacturing facilities.  A 
qualifying patient, registered caregiver, registered dispensary or manufacturing facility that 
engages in cannabis extraction using an inherently hazardous substance must comply with 
any rules regarding that activity adopted by the department by rule but is not required to 
obtain additional approvals or authorizations from the department to do so.
6.  It prohibits the department from posting on its publicly accessible website or 
otherwise making publicly available, except upon request, applications, supporting 
information and other nonconfidential information regarding a registered caregiver, 
including any address where the registered caregiver cultivates, manufactures, tests, 
packages, stores or sells cannabis plants or harvested cannabis under this chapter.  The bill 
directs the office to, as expeditiously as possible, remove from the office's website and 
otherwise from public availability, except upon request, any such nonconfidential 
information regarding registered caregivers.  
7.  It prohibits the department from requiring a caregiver retail store, registered 
dispensary, cannabis testing facility or manufacturing facility to use a form provided by the 
department to demonstrate municipal approval or other local authorization, if such approval 
or authorization is required by the municipality in which the store, dispensary or facility is 
seeking to operate.
8.  It provides that a caregiver retail store, registered dispensary, cannabis testing 
facility or manufacturing facility that was previously issued by the department a 
registration or other authorization to operate and was subsequently denied such registration 
or other authorization based solely on the failure of the store, dispensary or facility to obtain 
a completed form provided by the department to demonstrate municipal approval or other 
local authorization, or based solely on the failure of the municipality to adopt or amend an 
ordinance or approve a warrant article as required by law, is deemed in compliance with 
applicable municipal approval or local authorization requirements under the Act.  A 
caregiver retail store, registered dispensary, cannabis testing facility or manufacturing 
facility deemed in compliance with applicable municipal approval or local authorization 
requirements pursuant to this provision may request and the department shall issue a 
registration or other authorization to renew operations, provided that: the store, dispensary 
or facility is to be located in the same municipality in which it was located when last issued 
a registration or other authorization to operate by the department; and the store, dispensary 
or facility satisfies all other applicable registration or authorization requirements pursuant 
to the Act and adopted rules, excluding any such requirements relating to municipal 
approval or local authorization and any such requirements that the store, dispensary or 
facility maintain continuous operation since it was last issued a registration or other 
authorization to operate by the department.
9.  It provides that the Department of Administrative and Financial Services, in its 
annual report to the Legislature regarding the medical cannabis program, must include 
information regarding the gross sales of cannabis for medical use for the current and prior 
fiscal years.
10.  It directs the Department of Administrative and Financial Services, Office of 
Cannabis Policy, on or before January 9, 2026, to provisionally adopt and submit for 
legislative review major substantive rules necessary to implement the medical cannabis 
research grant program in accordance with the Maine Revised Statutes, Title 22, section 
2430, subsection 5.